A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBC
Trial details
- Registry ID
- NCT06663137
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Gemcitabine and docetaxel
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of NDV-01 in Participants With NMIBCNCT06663137 | RLMD | Phase 2 | Recruiting | 2027-11Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |